<!DOCTYPE HTML>
<html>
  <head>
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8">
	<title>Buprenorphine/ Naloxone</title>
	</head>
  <body onLoad="init();">
    <div data-role="page" data-theme="b">
  	<div data-role="header" data-theme="b" data-position="fixed">
    	<h1>Buprenorphine/ Naloxone</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-theme="b" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">
<h3>Brand name: Suboxone</h3>
<hr>
					<h3>Adult Starting Dose (Max Per Day)</h3>	
					<ul>
						<li>Specialty consultation advised </li>
						<li>Individualize dosing regimens</li>
					</ul>
<hr>
					<h3>Advantages</h3>	
					<ul>
						<li>FDA approved for management of Opioid dependence </li>
						<li>Combination product recommended for maintenance therapy not initial treatment </li>
						<li>Tablets contain either 2mg buprenorphine /0.5mg naloxone or 8mg buprenorphine /2mg naloxone</li> 
						<li>Addition of naloxone is intended to decrease the potential for parenteral abuse</li>
					</ul>
<hr>
					<h3>Disadvantages</h3>	
					<ul>
						<li>Major Adverse Effects: hepatitis, hepatic failure and respiratory depression (usually when misused intravenously with other CNS depressants) </li>
						<li>Common Adverse Effects: headache, pain, abdominal pain, insomnia, nausea, vomiting, sweating and constipation </li>
						<li>Tablets should be placed under tongue until dissolved; Tablets should not be swallowed. Drinking warm fluids prior to administration may aid in dissolution </li>	
					</ul>
<hr>
					<h3>Pregnancy Category</h3>	
					<ul>
							<li>Risk cannot be ruled out, but potential benefits may justify potential risk</li>	
					</ul>
<hr>
					<h3>Safety Margin for OATs</h3>	
					<ul>
						<li>Avoid concurrent use of buprenorphine with alcohol, st. johns wort, valerian and kava kava</li>
						<li>Serious overdose and death may occur if benzodiazepines, sedatives, tranquilizers, antidepressants, alcohol or other CNS depressants are taken in addition </li>
						<li>Avoid concurrent use of methadone with nilotinib, tetrabenazine, ziprasidone, alcohol, st. johns wort, valerian, kava kava and grapefruit juice</li> 
						<li>Methadone contraindicated with selegiline</li> 
						<li>Avoid concurrent use of buprenorphine with alcohol, st. johns wort, valerian and kava kava</li>
						
					</ul>
<hr>
					<h3>Efficacy for OATs</h3>	
					<ul>
						<li>Methadone is FDA approved for the management of moderate to severe pain</li>		
					</ul>



    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
